What kind of disease does Qu Bo have, why can t he play all the time?

Introduce you to this book Lian Kuoru wrote called Jianghu Cong Tan to know the ninth-rate black words.

It is difficult to question (ask).

Poverty) sickness (copies) plus.

Forced) not (and) wait.

out) life (in) death.

Laugh (and) die.

(Audit) suspicion (send) difficult.

100) Sickness (delivery) plus.

Laugh (and) die.

Forced) not (and) wait.

Same) life (altogether) death.

Blind) eyes (deaf).

(Audit) suspicion (send) difficult.

drunk) life (dream) death.

Laugh (and) die.

time) do not wait.

Same) life (altogether) death.

That one doesn't know Russia.

Oh, I'm sorry!!

Answering questions and solving problems, time does not wait, life and death together.

(Audit) suspicion (send) difficult.

drunk) life (dream) death.

Laugh (and) die.

time) do not wait.

I don't know if it's right, I really can't think of anything else, I'm sorry

Eltrombopag tablets.

English name] promacta, eltrombopag, revolade

Specification] tablets, 25mg tablets.

Indications] It is used for patients with chronic idiopathic thrombocytopenic purpura (ITP) after splenectomy who are ineffective with glucocorticoids and immunoglobulins.

Original manufacturer] GlaxoSmithKline (GSK) company.

Domestic and foreign approvals and listings].

In November 2008, it was approved by the FDA for marketing in the United States, and on November 19, 2012, it approved the small molecule thrombopoietin receptor agonist eltrombopag (trade name: Promacta) for thrombocytopenia in patients with chronic hepatitis C**. Outside of the United States, the drug is called revolade.

Since November 20, 2008, this product was first marketed in the United States as a short-term ** chronic idiopathic thrombocytopenic purpura (ITP) drug, and then successively launched in the United Kingdom on May 27, 2010, and has also been approved as a ** chronic ITP drug in more than 90 countries such as Canada, Russia, Kuwait, Chile and Venezuela.

Compared with the existing **thrombocytopenia drugs, eltrombopag is a **thrombocytopenia drug that can be administered orally, and the safety is high.

New Approved Indications: Eltrombopag (trade name: Promacta), a small molecule thrombopoietin receptor agonist, was approved on November 19, 2012 for thrombocytopenia in patients with chronic hepatitis C**.

Eltrombopag is the first supportive** drug approved for this type of patient. The approval of the new indication makes promacta the first supportive care drug for patients with chronic hepatitis C who are not suitable for initiating or maintaining an interferon reputation due to low platelet counts**. Approximately 4.2 million people in the country suffer from chronic hepatitis C, the most common bloodborne virus.

Some of these patients have a platelet count < 75,000 L and require a corresponding **.

A few days ago, the platelets of the father of the slag Chi fell below 10, with gamma globulin, prednisone, and terbiao** did not rise, and later the doctor recommended to buy eltrombopag in the socks of Walt Pharmacy in Hong Kong, the recommended dose was 25mg per day, and the platelets rose to 159 after 3 weeks, and the effect was still quite magical.

This is for patients with chronic idiopathic thrombocytopenic purpura (ITP) who are ineffective with transglucocorticoids, non-dermatologic peptoglobulin, or after splenectomy.

Now it's too expensive in the state.,Only the Indian version of the imitation is OK.,The efficacy is the same.,But it's not allowed to be sold in China.,I can only find someone to help bring it back.,I can also help if necessary.。

Eltrombopag is available in Bangladesh and is available in 40mg and 80mg sizes.

At the beginning of 2018, it was approved for listing in China, so it should be able to be bought.

This is not currently listed, China, Hong Kong has seen it, Walt Pharmacy.